Related Experiment Video
Updated: Aug 14, 2026
13:56
Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract
Published on: November 28, 2012
Cataract and the use of statins: a case-control study
L Smeeth1, R Hubbard, A E Fletcher
1Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK. liam.smeeth@lshtm.ac.uk
QJM : Monthly Journal of the Association of Physicians
|April 19, 2003
Summary
Statins do not appear to increase cataract risk in the short to medium term. Further research is needed to understand long-term statin effects on eye health.
Area of Science:
- Pharmacology
- Ophthalmology
- Epidemiology
Background:
- Animal studies suggest statins may induce cataract formation.
- Human studies have been limited in excluding a clinically significant effect due to the rarity of cataracts.
Purpose of the Study:
- To evaluate the risk of cataract associated with statin use.
- To determine if concurrent use of cytochrome P450 inhibiting drugs amplifies statin-related cataract risk.
Main Methods:
- A population-based case-control study design was employed.
- Data from 15,479 cataract cases and 15,479 matched controls were analyzed from the UK General Practice Research Database.
Main Results:
- The initial association between statin exposure and cataract (OR 1.41) was not significant after adjusting for consultation rates (OR 1.04).
- No increased risk was observed with higher statin doses, longer duration of use, or specific statin types.
- Concurrent use of statins and cytochrome P450 inhibitors did not elevate cataract risk.
Conclusions:
- Short- and medium-term statin use does not appear to be linked to an increased risk of cataract.
- Long-term effects of statin exposure on ocular health require further investigation.
